M&A Advisor in Hangzhou Looking to Buyout Healthcare Businesses Upto USD 70 thousand

A subsidiary of an enterprise founded in 1993 and headquartered in Beijing, we are a leading investment, operation, and management group in China, with a presence in over 50 countries globally and annual sales of approximately RMB200 bn (c. US$30.8 bn1).
• The pharmaceutical and healthcare business represents a core.
Focus area for the group and comprises 40+ companies with total sales of.
RMB38 bn (US$5.8 bn) in 2017.
• On a consolidated basis, we ranked among the top 5 manufacturers by sales in the Chinese pharmaceutical market in 2017.
• We have established four major industrial platforms: (i) Generic pharma; (ii) Specialty pharma; (iii) Traditional Chinese Medicine (TCM); and (iv) bio-pharmaceuticals.
Our focus is a cross-border and domestic license (license-in, including both clinical stage and commercial-stage products), tech transfer, acquisition, distribution, and co-development of live biotherapeutic products, and investment in novel microbiome Research platforms.

Acquiring / Buying a Business, Investing in a Business, Lending to a Business, Buying Business Assets, Taking up a Franchise / Distributorship / Sales Agency

Looking for an established company with good ROI.

• Connected with 2 businesses
• Received 1 proposal
• Earlier than 15 days

  Received a proposal from For Sale: Non-operating start-up womens health retreat & supplement business catering to luxury resort/spa industry.